- Home
- TYGO vs MDCX Comparison
TYGO vs MDCX Comparison
Compare TYGO & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYGO
- MDCX
- Stock Information
- Founded
- TYGO 2007
- MDCX 2008
- Country
- TYGO United States
- MDCX Canada
- Employees
- TYGO N/A
- MDCX N/A
- Industry
- TYGO Semiconductors
- MDCX
- Sector
- TYGO Technology
- MDCX
- Exchange
- TYGO Nasdaq
- MDCX Nasdaq
- Market Cap
- TYGO 60.2M
- MDCX 48.4M
- IPO Year
- TYGO N/A
- MDCX N/A
- Fundamental
- Price
- TYGO $1.00
- MDCX $2.60
- Analyst Decision
- TYGO Strong Buy
- MDCX Strong Buy
- Analyst Count
- TYGO 2
- MDCX 2
- Target Price
- TYGO $3.75
- MDCX $23.50
- AVG Volume (30 Days)
- TYGO 21.1K
- MDCX 383.9K
- Earning Date
- TYGO 05-06-2025
- MDCX 05-12-2025
- Dividend Yield
- TYGO N/A
- MDCX N/A
- EPS Growth
- TYGO N/A
- MDCX N/A
- EPS
- TYGO N/A
- MDCX N/A
- Revenue
- TYGO $63,051,000.00
- MDCX N/A
- Revenue This Year
- TYGO $69.44
- MDCX N/A
- Revenue Next Year
- TYGO $21.75
- MDCX N/A
- P/E Ratio
- TYGO N/A
- MDCX N/A
- Revenue Growth
- TYGO N/A
- MDCX N/A
- 52 Week Low
- TYGO $0.58
- MDCX $1.80
- 52 Week High
- TYGO $1.85
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- TYGO 60.26
- MDCX N/A
- Support Level
- TYGO $0.92
- MDCX N/A
- Resistance Level
- TYGO $1.04
- MDCX N/A
- Average True Range (ATR)
- TYGO 0.06
- MDCX 0.00
- MACD
- TYGO 0.00
- MDCX 0.00
- Stochastic Oscillator
- TYGO 75.00
- MDCX 0.00
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.